Status:
COMPLETED
MD2Me - Texting to Promote Chronic Disease Management
Lead Sponsor:
Huang, Jeannie, M.D.
Collaborating Sponsors:
University of California, San Diego
Conditions:
Cystic Fibrosis
Inflammatory Bowel Disease
Eligibility:
All Genders
14-22 years
Phase:
NA
Brief Summary
UCSD researchers are conducting a study aimed to develop and evaluate a chronic disease self management web and text message based program on health-related self-efficacy and frequency of adolescent-c...
Detailed Description
The MD2Me study (or also known as TAHLC), sponsored by the National Institutes of Health is a 2-year randomized controlled trial to develop and test a text message and Internet based intervention amon...
Eligibility Criteria
Inclusion
- ages 14 - 22 years
- have cystic fibrosis, type 1 diabetes, or inflammatory bowel disease for at least 6 months
- have access to the internet
- speak English
- has a parent that speaks English or Spanish (if primary participant is under 18)
- willingness to attend assessment visits
Exclusion
- pregnant or have children
- have a history of substance abuse or other psychiatric disorder that would impair compliance with study protocol
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT01253733
Start Date
October 1 2009
End Date
March 1 2012
Last Update
January 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Diego
La Jolla, California, United States, 92093